# US 2015/0104560 A1 · Method and device for radiotherapy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0104560 A1
- Document ID: US20150104560A1
- Status: Published application
- Kind: A1
- Application number: 14/551,273
- Filed: 2014-11-24
- Published: 2015-04-16
- Earliest claimed: 2003-04-30
- Assignees: Althera Medical Ltd.
- Applicants: Althera Medical Ltd.
- Inventors: Itzhak KELSON; Lior Arazi
- Web page: https://patentgrep.com/patent/US20150104560A1

## CPC

- A61N 5/1015: {Treatment of resected cavities created by surgery, e.g. lumpectomy}
- A61B 1/00087: {Tools (A61B17/00234 takes precedence)}
- A61B 1/018: for receiving instruments
- A61B 1/3132: {for laparoscopy}
- A61B 17/3468: {for implanting or removing devices, e.g. prostheses, implants, seeds, wires (devices for implanting seeds A61M37/0069)}
- A61K 51/1282: {Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents}
- A61N 5/1007: {Arrangements or means for the introduction of sources into the body}
- A61N 5/1027: {Interstitial radiation therapy}
- A61P 35/00: Antineoplastic agents
- C23C 14/06: characterised by the coating material ({C23C14/0021} , C23C14/04 take precedence)
- C23C 14/48: Ion implantation
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 2121/00: Preparations for use in therapy
- A61N 5/1001: {using radiation sources introduced into or applied onto the body; brachytherapy}
- A61N 2005/1008: {Apparatus for temporary insertion of sources, e.g. afterloaders}
- A61N 2005/1024: {Seeds}
- A61N 2005/1087: {Ions; Protons}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C23C: COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL (making metal-coated products by extrusion B21C23/22; covering with metal by connecting pre-existing layers to articles, see the relevant places, e.g. B21D39/00, B23K; metallising of glass C03C; metallising mortars, concrete, artificial stone, ceramics or natural stone C04B41/00; enamelling of, or applying a vitreous layer to, metals C23D; treating metal surfaces or coating of metals by electrolysis or electrophoresis C25D; single-crystal film growth C30B; by metallising textiles D06M11/83; decorating textiles by locally metallising D06Q1/04)

## Abstract

A radiotherapy method, comprising positioning a predetermined amount of a radionuclide selected from the group consisting of Radium-223, Radium-224, Radon-219 and Radon-220, in proximity to and/or within a tumor of a subject, for a predetermined time period. The predetermined amount and the predetermined time period are selected sufficient for the radionuclide to administering a predetermined therapeutic dose of decay chain nuclei and alpha particles into the tumor.

## Claims

### Claim 1

A method of manufacturing a radiotherapy device, the method comprising:
providing a probe having a surface;
positioning said surface in a flux of a radionuclide selected from the group consisting of Radium-223 and Radium-224; and
collecting atoms of said radionuclide to retainably embed said atoms on or beneath said surface, and to ensure that said radionuclide remains in said probe while a therapeutic dose of decay chain nuclei and alpha particles of said radionuclide is emitted outside said surface, thereby manufacturing the radiotherapy device.

### Claim 2 (depends on 1)

The method of claim 1, wherein said collecting is by direct implantation in a vacuum.

### Claim 3 (depends on 1)

The method of claim 1, wherein said collecting is by connecting said surface to a voltage source of negative polarity.

### Claim 4 (depends on 3)

The method of claim 3, wherein said positioning of said surface in said flux of said radionuclide is in a gaseous environment.

### Claim 5 (depends on 3)

The method of claim 3, wherein a pressure of said gaseous environment and a voltage of said voltage source are selected such that a velocity of nuclei is reduced to a thermal velocity.

### Claim 6 (depends on 1)

The method of claim 1, wherein said probe is selected such that the device is removably implantable in a body of a subject.

### Claim 7 (depends on 1)

The method of claim 1, wherein said probe comprises at least one needle.

### Claim 8 (depends on 1)

The method of claim 1, wherein said probe comprises at least one bead.

### Claim 9 (depends on 1)

The method of claim 1, wherein said probe is a tip of an endoscope.

### Claim 10 (depends on 1)

The method of claim 1, wherein said probe is a tip of a laparoscope.

### Claim 11 (depends on 1)

The method of claim 1, wherein said probe is a tip of an imaging device.

### Claim 12 (depends on 1)

The method of claim 1, wherein said probe comprises an inner elongated member and an outer tubular member having a mouth section configured for receiving said inner elongated member, said inner elongated member being movable within said outer tubular member and having a distal end and a proximal end, whereby said radionuclide is collected on or beneath a surface of said distal end.

### Claim 13 (depends on 1)

The method of claim 1, further comprising coating said surface by a protective coat.

### Claim 14 (depends on 13)

The method of claim 13, wherein at least one of a thickness and a material of said protective coat is selected so as not to prevent emission of decay chain nuclei and alpha particles from said surface of said probe.

### Claim 15 (depends on 1)

The method of claim 1, wherein said probe is capable of administering from about 100 rem to about 100000 rem of radiation dose.

### Claim 16 (depends on 1)

The method of claim 1, wherein an activity of said radionuclide is from about 10 nanoCurie to about 10 microCurie.

### Claim 17

A method of preparing a radioactive surface source, the method comprising:
providing a solution containing a predetermined amount of a radioactive isotope; and
spreading said solution on a metal surface so as to provide an admixture of said metal and said solution, wherein a thickness of a said solution over said metal surface is sufficiently small to allow recoiling of decay chain nuclei resulting from alpha decay of said radioactive isotope out of said admixture, thereby providing said radioactive surface source.

### Claim 18 (depends on 17)

The method of claim 17, wherein said radioactive isotope comprises Thorium-228.

### Claim 19 (depends on 17)

The method of claim 17, wherein said solution is acidic solution.

### Claim 20 (depends on 19)

The method of claim 19, wherein said acidic solution comprises hydrochloric acid.
